Diabetes and the eye

Diabetes mellitus is now a global emergency and the eye is one of the organs that can be most severely affected by its complications. Prevention, early diagnosis and appropriate treatment are our most important resources for combating it.    

Diabetes mellitus is a chronic disease caused by insufficient secretion of insulin by the pancreas or the human body's inability to utilise insulin.

Some of the most serious eye diseases that can affect diabetic patients are: diabetic retinopathy, diabetic macular oedema, which sometimes occurs precisely as a complication of diabetic retinopathy, glaucoma and cataracts.

 

Diabetic retinopathy

Diabetic retinopathy is one of the leading causes of blindness in the world and its prevalence is expected to double in the next decade. The onset of this disease in diabetic patients is linked to high blood glucose levels, which induces damage to the retinal microcirculation.

A correct classification of diabetic retinopathy is essential in order to direct the choice of the most appropriate therapy and determine the prognosis of the disease.

In a study of patients with type 2 diabetes, it was found that there are three phenotypes by which to classify different types of retinopathy: A, B and C. Type C has the highest risk of worsening, as well as a greater likelihood of developing complications that can severely impair vision. Phenotype A, on the other hand, presents the lowest risk of worsening and development of complications.

This is why correct diagnosis and classification of this pathology are so important. Today, it is possible to use tests that are quite simple to perform, such as colour photography of the fundus and optical coherence tomography, which can be repeated without great inconvenience for the patient or difficulty for the clinical staff. In fact, one must bear in mind that any person with type 1 or type 2 diabetes or gestational diabetes (the form of diabetes that can occur during pregnancy) can develop a form of diabetic retinopathy.

Glaucoma

Glaucoma is a chronic, progressive eye disease that results in irreversible damage to the optic nerve, the main cause of which is identified as elevated intraocular pressure (IOP).

Glaucoma is characterised by the gradual and progressive death of retinal ganglion cells and is one of the leading causes of irreversible vision loss worldwide.

An association between diabetes and glaucoma has been demonstrated, particularly with primary open-angle glaucoma (POAG), which is in fact the most frequent form of glaucoma diagnosed in individuals with diabetes and, in general, the most common type in the population.

The main risk factors for primary open-angle glaucoma include:

  • Advanced age
  • Positive family history for the disease
  • African ethnicity
  • Thinning of the central corneal thickness
  • Systemic arterial hypertension
  • Diabetes
  • Myopia

Cataracts

Diabetes affects all ocular structures, but the crystalline lens and retina are undoubtedly among the ocular districts that can be most significantly affected.

Osmotic, refractive and accommodative alterations of the crystalline lens have been demonstrated in diabetic patients, as well as an increased risk of cataracts, since cataracts arise precisely as a result of opacification of this ocular structure.

Cataracts, along with diabetic retinopathy and glaucoma, are also a major cause of blindness worldwide.

Prevention through close monitoring of haematological parameters, early diagnosis and timely treatment can be decisive in preserving visual function in people with diabetes.

For this reason, all diabetic patients, but especially the elderly, should visit an ophthalmologist regularly to diagnose and treat any ocular complications related to this serious systemic disease in a timely manner.

Bibliografia

World Health Organisation (2022, September 16th) https://www.who.int/news-room/fact-sheets/detail/diabetes

Diabetes and Vision Loss (2022, December 19th). Centers for Disease Control and Prevention. https://www.cdc.gov/diabetes/managing/diabetes-vision-loss.html

Diabetic Eye Disease (2023, February 10th). National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/diabetes/overview/preventing-problems/diabetic-eye-disease

Diabetic Retinopathy: Causes, Symptoms, Treatment (2022, September 9th). American Academy of Ophthalmology. https://www.aao.org/eye-health/diseases/what-is-diabetic-retinopathy

Marqués, I. P., Madeira, M. H., Messias, A. L., Martinho, A. C. V., Santos, T., Sousa, D. C., Figueira, J., & Cunha-Vaz, J. (2020). Different retinopathy phenotypes in type 2 diabetes predict retinopathy progression. Acta Diabetologica, 58(2), 197-205. DOI: 10.1007/s00592-020-01602-9

Diabetes and risk of glaucoma: systematic review and a Meta-analysis of prospective cohort studies. (2017, 18 Septiembre). International Journal of Ophthalmology. https://doi.org/10.18240/ijo.2017.09.16
Rhee, D. J. (2023, 6 febrero). Primary-open-angle . Manual MSD versión para profesionales. https://www.msdmanuals.com/professional/eye-disorders/glaucoma/primary-open-angle-glaucoma

Silva Pacheco, M., & Chacón Chavez, K. (2020). Diabetes mellitus type 2: Cambios densitométricos del cristalino. Rev DigitPostgrade. 9(1): e187. DOI: 10.37910/RDP.2020.9.1.e187

 C'è molto di più per te se ti iscrivi qui

Mandaci i tuoi commenti, le tue richieste e le tue proposte per arricchire i contenuti del nostro portale.

    This site is protected by reCAPTCHA. The conditions of use indicated in the Privacy Policy.